{
  "id": 14914332,
  "title": "London’s Unravel Health raises €2.96 million to help women track hormones at home with a palm-sized lab",
  "url": "https://urgent.news/2026/10/16/londons-unravel-health-raises-2-96-million-to-help-women-track",
  "topic": "business",
  "section": "Business",
  "published": "2026-10-16T08:52:14.000Z",
  "source": {
    "name": "EU-Startups",
    "slug": "eu-startups",
    "url": "https://www.eu-startups.com/2026/10/londons-unravel-health-raises-e2-96-million-to-help-women-track-hormones-at-home-with-a-palm-sized-lab/"
  },
  "original_language": "en",
  "account": "London-based Unravel Health, a startup developing home hormone measurement technology, has secured €2.96 million (£2.5 million) to create the Micro Lab, a portable device that reads multiple hormones from saliva samples in minutes. The funding round was led by Conduit EIS Impact Fund and Wrightwood, with participation from Leo Capital, Embryo Ventures, Hermesa, and returning investor Zinc VC. Veronika Bridgman, co-founder and CEO, explains that the Micro Lab aims to bring a lab into the home, enabling women to monitor their hormonal health between blood tests and wearables, which only provide estimates. The technology, developed over ten years at the University of Glasgow, is protected by three patents and has been used to measure markers for heart health and prostate cancer. Bridgman highlights the market need, stating that women's hormonal health is largely underserved, with existing solutions capturing data at a single point in time or providing estimates through wearables. The Micro Lab will read oestradiol, alongside three other key hormones, and is designed for use throughout different life stages, from puberty to perimenopause. The funding will support external equivalency studies, the addition of new markers, and the beginning of the regulatory approval process, with the goal of launching the first early-access devices by 2027.",
  "summary": "Unravel Health, a London-based startup developing technology to measure hormones at home daily, has raised €2.96 million (£2.5 million) to develop the Micro Lab, a palm-sized device that reads multiple hormones from a saliva sample in minutes. The round was led by Conduit EIS Impact Fund and Wrightwood, joined by Leo Capital, Embryo Ventures, Hermesa […] The post London’s Unravel Health raises…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}